Literature DB >> 33163964

Acute recurrent bradycardia with evoked potential loss during transforaminal lumbar interbody fusion.

C P Schwan1, M R Pedersen1, K Tavanaiepour1, D Tavanaiepour1, A L Hoefnagel1, P D Mongan1.   

Abstract

During a transforaminal lumbar interbody fusion a patient experienced acute intermittent bradycardia with manipulation of the intervertebral body space, followed by loss of somatosensory evoked potentials that did not recover. Postoperative evaluation revealed new bilateral lower extremity sensory and motor deficits. We postulate an afferent reflex arc to explain this and other reported instances of bradycardia and asystole during transforaminal lumbar interbody fusion surgery. Awareness of the association between bradycardia during lumbar spine surgery may alert anaesthetists, surgeons and neuromonitoring teams to impending neurological harm.
© 2020 Association of Anaesthetists.

Entities:  

Keywords:  SSEP: physiological effects; bradycardia; lumbar nerve roots: innervation; spinal cord: anatomy

Year:  2020        PMID: 33163964      PMCID: PMC7605407          DOI: 10.1002/anr3.12049

Source DB:  PubMed          Journal:  Anaesth Rep        ISSN: 2637-3726


  9 in total

1.  Lumbo-sacral spine surgery and severe bradycardia.

Authors:  Alain Deschamps; George Carvalho
Journal:  Can J Anaesth       Date:  2004-03       Impact factor: 5.063

2.  More on lumbo-sacral spine surgery and bradycardia.

Authors:  Nanda Gopal Mandal
Journal:  Can J Anaesth       Date:  2004-11       Impact factor: 5.063

3.  Dural Traction a Possible Cause of Hemodynamic Changes During Single-Level Transforaminal Lumbar Interbody Fusion.

Authors:  Jonathan M Weimer; Martin Marinov; Rafi Avitsian
Journal:  World Neurosurg       Date:  2016-10-07       Impact factor: 2.104

4.  Best Practices in Intraoperative Neuromonitoring in Spine Deformity Surgery: Development of an Intraoperative Checklist to Optimize Response.

Authors:  Michael G Vitale; David L Skaggs; Gregory I Pace; Margaret L Wright; Hiroko Matsumoto; Richard C E Anderson; Douglas L Brockmeyer; John P Dormans; John B Emans; Mark A Erickson; John M Flynn; Michael P Glotzbecker; Kamal N Ibrahim; Stephen J Lewis; Scott J Luhmann; Anil Mendiratta; B Stephens Richards; James O Sanders; Suken A Shah; John T Smith; Kit M Song; Paul D Sponseller; Daniel J Sucato; David P Roye; Lawrence G Lenke
Journal:  Spine Deform       Date:  2014-08-27

Review 5.  Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings.

Authors:  Enrique Coss-Adame; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2014-04

Review 6.  Visceral Pain.

Authors:  Luke Grundy; Andelain Erickson; Stuart M Brierley
Journal:  Annu Rev Physiol       Date:  2018-10-31       Impact factor: 19.318

Review 7.  Medical Error Avoidance in Intraoperative Neurophysiological Monitoring: The Communication Imperative.

Authors:  Stan Skinner; Robert Holdefer; John J McAuliffe; Francesco Sala
Journal:  J Clin Neurophysiol       Date:  2017-11       Impact factor: 2.177

Review 8.  The negative chronotropic effect during lumbar spine surgery: A systemic review and aggregation of an emerging model of spinal cardiac reflex.

Authors:  Tumul Chowdhury; Bernhard Schaller
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

9.  Comparison of low back fusion techniques: transforaminal lumbar interbody fusion (TLIF) or posterior lumbar interbody fusion (PLIF) approaches.

Authors:  Chad D Cole; Todd D McCall; Meic H Schmidt; Andrew T Dailey
Journal:  Curr Rev Musculoskelet Med       Date:  2009-04-29
  9 in total
  1 in total

1.  A Loading Dose of Dexmedetomidine With Constant Infusion Inhibits Intraoperative Neuromonitoring During Thoracic Spinal Decompression Surgery: A Randomized Prospective Study.

Authors:  Tun Liu; Yue Qin; Huaguang Qi; Zhenguo Luo; Liang Yan; Pengfei Yu; Buhuai Dong; Songchuan Zhao; Xucai Wu; Zhen Chang; Zhian Liu; Xuemei Liu; Tao Yuan; Houkun Li; Li Xiao; Gang Wang
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.